- Previous Close
0.0000 - Open
2.6500 - Bid 2.0200 x 40000
- Ask 2.6500 x 40000
- Day's Range
2.6500 - 2.6500 - 52 Week Range
1.8200 - 3.8700 - Volume
300 - Avg. Volume
2,981 - Market Cap (intraday)
2.806B - Beta (5Y Monthly) 0.45
- PE Ratio (TTM)
10.78 - EPS (TTM)
0.2300 - Earnings Date --
- Forward Dividend & Yield 0.10 (4.22%)
- Ex-Dividend Date Oct 21, 2024
- 1y Target Est
--
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers single use medical consumables and materials, including infusion sets, syringes, blood bags and blood component segregators consumable, blood sampling products, prefilled syringes for pre-pack medication and medical needles which mainly include intravenous needles, syringe needles, intravenous catheter needles, blood sampling needles and irregular needles; orthopedic materials and instruments, including trauma products of steel plates and screws, spinal implants, and artificial joints; and blood purification consumables and equipment, including puncture needles, extracorporeal blood circuit for blood purification sets, dialyzers and related consumables. It also provides tumour and blood vessel interventional instruments; flushing syringes; blood collection, irradiation, storage, separation and sterilization products; implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; medical polymer materials and products; injection puncture Instruments; medicines; and X-ray based irradiation machines. In addition, it is involved in the finance leasing and factoring business; provision of enterprise management advisory services, logistics and storage, and computer technical services; and sale of electronic products. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
www.weigaogroup.com12,606
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Recent News: SHWGY
View MorePerformance Overview: SHWGY
Trailing total returns as of 12/13/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHWGY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHWGY
View MoreValuation Measures
Market Cap
2.81B
Enterprise Value
2.29B
Trailing P/E
10.73
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.57
Price/Book (mrq)
0.88
Enterprise Value/Revenue
1.28
Enterprise Value/EBITDA
6.58
Financial Highlights
Profitability and Income Statement
Profit Margin
14.74%
Return on Assets (ttm)
3.77%
Return on Equity (ttm)
8.18%
Revenue (ttm)
12.97B
Net Income Avi to Common (ttm)
1.91B
Diluted EPS (ttm)
0.2300
Balance Sheet and Cash Flow
Total Cash (mrq)
7.87B
Total Debt/Equity (mrq)
16.76%
Levered Free Cash Flow (ttm)
1.03B